Search results
Dosage and administration. Unless prescribed otherwise, take 1-2 sachets of Hepa-Merz ® 1-2 times daily. Dissolve the contents of the sachet in plenty of liquid (glass of water, tea or juice), and drink after meals. If required, the dosage may be increased without risk.
Hepa-Merz® – convenient and easy to use in HE. rnithine-L-aspartate; L. ing pharmaceutical forms:1 Granules: Hepa-Merz® sachet contains 3 g of LOLA. ing Hepa-Merz® for the management of all stages of HEHepa-Merz® indications: Treatment of concomitant disease and sequelae due to impaired deto.
Home – Hepa-Merz®: Professional Website
Dosage Leaflet. Optimal use of Hepa Merz in HE. Obligatory texts Hepa-Merz ®. EU: Hepa- Merz® Granules. Active substance: L-ornithine- L-aspartate. Indications: Treatment of concomitant disease and sequelae due to impaired detoxification activity (e.g. in cirrhosis of the liver) with the symptoms of latent and manifest hepatic encephalopathy.
Learn more about Hepa-Merz drug profile, safety and efficacy of Hepa-Merz, pharmaceutical forms, dosing and clinical study experience with the drug. Make yourself familiar with the prescribing info and important scientific data, including clinical experience.
Produkt leczniczy Hepa-Merz nie powinien być podawany pacjentom: - z niewydolnością nerek znacznego stopnia (stężenie kreatyniny w surowicy powyżej 3 mg/100 ml); - z zaburzeniami metabolizmu aminokwasów biorących udział w cyklu mocznikowym, np. na skutek defektu enzymatycznego.
Hepa- Merz® Granules. Active substance: L-ornithine- L-aspartate. Indications: Treatment of concomitant disease and sequelae due to impaired detoxification activity (e.g. in cirrhosis of the liver) with the symptoms of latent and manifest hepatic encephalopathy. Contains orange yellow S (E110), fructose, aspartame.
